Free CME from PeerView


Pathology CME

Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Navigating Complex Decisions at the Intersection of Local and Systemic Management of Early Breast Cancer
March 24, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Harnessing the Power of Immunotherapy in Resectable Melanoma: Guidance for Delivering Effective Adjuvant and Neoadjuvant Strategies
March 22, 2023
Credits: 1.0 CME / CC
PVI, PeerView Institute for Medical Education
Gaining Confidence in Predicting and Assessing Response to Cancer Immunotherapies: Practical Strategies for Biomarker Testing and Pathologic Response Assessment
March 14, 2023
Credits: 1.5 CME / MOC / CC
PVI, PeerView Institute for Medical Education
A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer: Exploring the Biology and Updating Best Practices for Testing and Treatment
March 13, 2023
Credits: 1.5 CME / CC
PVI, PeerView Institute for Medical Education
The Precision Team in AML: Exploring Pathologist-Informed Clinical Decisions in Challenging AML Settings
March 13, 2023
Credits: 1.0 CME / MOC / CC
PVI, PeerView Institute for Medical Education
Seizing the Precision Care Moment in MDS: Collaborative Strategies for Accurate Diagnoses and Risk-Adapted Treatment
March 13, 2023
Credits: 1.0 CME / CC
PVI, PeerView Institute for Medical Education
Refining Best Practices in Cancer Immunotherapy Biomarker Testing and Pathologic Response Assessment
March 02, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Perfecting Precision in Modern NSCLC Practice: Are You Optimally Integrating Biomarker-Driven Therapy?
February 27, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Refining Precision Decisions in NSCLC With Common and Less Common EGFR Mutations: Navigating Testing and Treatment Throughout the Disease Continuum
February 23, 2023
Credits: 1.0 CME / MOC / CC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Fine-Tuning Biomarker Testing to Identify and Target RET Fusions as Uncommon But Actionable Genomic Alterations in NSCLC
January 30, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How to Modernize Best Practices Based on New Evidence and Better Multidisciplinary Alliances
January 21, 2023
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
September 29, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Optimizing NTRK Fusion Testing and TRK Inhibition in Thyroid Cancer: Team-Based Approaches for Enhanced Outcomes
September 26, 2022
Credits: 1.0 CME / MOC / NCPD
Medical Learning Institute, Inc.
Improving Clinical Care With Newer, Better Therapies for Targeting Actionable Gene Fusions in NSCLC
September 02, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance With Targeted Agents
July 01, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Find the Targets, Treat With Precision: Modern Principles and New Advances in Biomarker-Driven Lung Cancer Care
June 05, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
The Power and Promise of Immunotherapy in Head and Neck Cancer: How Established and Emerging Immune-Based Options Can Enhance Patient Care
June 05, 2022
PVI, PeerView Institute for Medical Education
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers
April 10, 2022
Michael Heinrich, MD
Medical Learning Institute, Inc.
Optimally Sequencing Modern TKIs in GIST: Expert Perspectives From an Interprofessional Sarcoma Team
January 13, 2022